ライフサイエンスコーパス: endobronchial

1 istribution (standard error, percutaneous vs endobronchial: 0.13 vs 0.07, respectively; P = .03).

2 ing endobronchial injection (percutaneous vs endobronchial, 4.8 cm(3) [95% confidence interval: 3.6,

3 ermined by computerized tomography (CT), and endobronchial abnormalities at bronchoscopy; (2) number,

4 Using a murine model, we demonstrated that endobronchial administration of antibodies (Abs) to majo

5 Despite endobronchial administration, animals treated with hMSCs

6 choalveolar space and change in FEV(1) after endobronchial allergen challenge (EBAC) in atopic asthma

7 e regional allergic reaction after segmental endobronchial allergen challenge.

8 ne challenge, inhaled allergen challenge and endobronchial allergen provocation through a bronchoscop

9 choline and inhaled allergen challenges, and endobronchial allergen provocations through a bronchosco

10 went two bronchoscopies with proximal airway endobronchial and distal alveolar tissue transbronchial

11 went two bronchoscopies with proximal airway endobronchial and distal alveolar tissue transbronchial

12 Endobronchial and transbronchial biopsies were performed

13 Similar results were obtained in the endobronchial and transbronchial biopsy specimens, which

14 Sections of concurrently obtained endobronchial and transbronchial/surgical biopsy tissue

15 ablation zone size is observed by using the endobronchial approach.

16 transplantation, usually in association with endobronchial bacterial infection.

17 0 days after transplantation (n = 11) and/or endobronchial biopsies (n = 14) at 30 days for real-time

18 amined in blood, bronchoalveolar lavage, and endobronchial biopsies 48 hours after challenge.

19 the change in ASM transcriptomic profile in endobronchial biopsies after 14 days of oral glucocortic

20 expression of the protein phosphatase PP5 in endobronchial biopsies and ASM cells.

21 performed 6 h after each exposure to obtain endobronchial biopsies and bronchial wash (BW) cells.

22 Endobronchial biopsies and bronchoalveolar lavage fluid

23 itative computed tomography of the lungs and endobronchial biopsies and brushings were obtained in 51

24 protein-protein interactions are observed in endobronchial biopsies and fresh epithelial cells from a

25 We evaluated lymphocytic bronchitis on endobronchial biopsies as a risk factor for BOS and mort

26 compared the ASM transcriptomic profiles of endobronchial biopsies between glucocorticoid-free, atop

27 Intracellular mucins were measured in endobronchial biopsies by immunohistochemistry and gene

28 e chain reaction and immunohistochemistry in endobronchial biopsies from 13 subjects with mild and mo

29 hree different collagen staining methods, in endobronchial biopsies from 17 severe, nine moderate, an

30 y and quantitative real-time PCR analysis of endobronchial biopsies from 27 mild-to-moderate asthmati

31 tion of the bronchial epithelium observed in endobronchial biopsies from asthmatic subjects is a true

32 e that denudation of bronchial epithelium in endobronchial biopsies from asthmatic subjects with stab

33 eta2, and mucin expression were evaluated in endobronchial biopsies from asthmatics and normal subjec

34 mune processes based on RNA-Seq profiling of endobronchial biopsies from high-risk smokers.

35 We compared ASM cultured from endobronchial biopsies from subjects with and without as

36 The network was further tested using endobronchial biopsies from two data cohorts, containing

37 Immunohistochemical staining of endobronchial biopsies identified epithelial localizatio

38 ion was also increased in the ASM bundles in endobronchial biopsies in severe asthmatics.

39 lls were determined in ultrathin sections of endobronchial biopsies obtained from 53 infants during c

40 gene expression profile of the ASM layer in endobronchial biopsies of patients with asthma is altere

41 eosin-stained whole slide images to stratify endobronchial biopsies of PMLs across a spectrum from no

42 Immunohistochemical staining of endobronchial biopsies revealed that KCa3.1 channels are

43 Immunohistochemical analyses of endobronchial biopsies showed a remarkable loss of caveo

44 atial transcriptomics of pediatric asthmatic endobronchial biopsies suggests intense vascular stress

45 Endobronchial biopsies were collected and graded during

46 an respiratory epithelial cells derived from endobronchial biopsies were cultured using a combination

47 Endobronchial biopsies were performed at the end of 12 w

48 dilation (DeltaR(rs) ) and bronchoscopy with endobronchial biopsies were performed.

49 Endobronchial biopsies were taken before and after 14 da

50 e, respectively), as well as mucosal tissue (endobronchial biopsies).

51 gene expression, quantitative morphometry of endobronchial biopsies, and levels of secreted protein.

52 W and correlated with collagen deposition in endobronchial biopsies.

53 pression in bronchoalveolar lavage cells and endobronchial biopsies.

54 r each exposure to obtain airway lavages and endobronchial biopsies.

55 vere asthma (N-SA; n = 8) were cultured from endobronchial biopsies.

56 challenge, and fiberoptic bronchoscopy with endobronchial biopsy (always right upper lobe second-gen

57 IL-33 expression was quantified in endobronchial biopsy (EB) specimens from children with S

58 induction, bronchoalveolar lavage (BAL) and endobronchial biopsy (EB).

59 e of macrophages/DC in lung allografts using endobronchial biopsy (EBB) and transbronchial biopsy (TB

60 ession of paired airway epithelial brush and endobronchial biopsy samples was compared between 60 RA

61 ant diisocyanate-conjugated protein in human endobronchial biopsy samples, whereas albumin was the pr

62 ed and quantified by immunohistochemistry in endobronchial biopsy sections from smoking and non-smoki

63 We sought to determine endobronchial biopsy specimen ASM area fraction in presc

64 hiolitis defined by pathological criteria on endobronchial biopsy specimens (in heart-lung/lung patie

65 microscopy, and SHG microscopy in PSW and SA endobronchial biopsy specimens and in HDM-exposed neonat

66 Endobronchial biopsy specimens from allergen-challenged

67 lly differentiated bronchial epithelium from endobronchial biopsy specimens maintain inherent phenoty

68 Primary human fibroblasts were cultured from endobronchial biopsy specimens obtained from healthy or

69 nflammatory imbalances initially observed in endobronchial biopsy specimens obtained from patients wi

70 ultures of bronchial epithelium derived from endobronchial biopsy specimens of patients with differen

71 uman bronchial epithelial cells derived from endobronchial biopsy specimens of patients with mild and

72 and ASM mast cell values were quantified in endobronchial biopsy specimens previously obtained from

73 oduction, were assessed in paraffin-embedded endobronchial biopsy specimens to evaluate morphologic c

74 e density of FABP4-immunoreactive vessels in endobronchial biopsy specimens was significantly higher

75 Endobronchial biopsy specimens, epithelial brushings, an

76 y using the immunohistochemistry results for endobronchial biopsy specimens.

77 eology was used to quantify BMZ thickness in endobronchial biopsy tissue sections from 109 patients w

78 inophils, followed by bronchoscopy, BAL, and endobronchial biopsy within 24 h.

79 nological sampling of blood, induced sputum, endobronchial biopsy, and bronchoalveolar lavage for flo

80 ical assessment and provided induced sputum, endobronchial biopsy, bronchoalveolar lavage, and blood

81 CS-dependent asthmatics were evaluated with endobronchial biopsy, pulmonary function, allergy testin

82 nchoscopy, bronchoalveolar lavage (BAL), and endobronchial biopsy.

83 epithelial and endothelial cells obtained by endobronchial biopsy.

84 putum induction, bronchoalveolar lavage, and endobronchial biopsy.

85 An endobronchial blocker was placed into the left main stem

86 ous positive airway pressure applied via the endobronchial blocker.

87 ion therapy were treated with palliative HDR endobronchial brachytherapy for symptoms due to relapse

88 HDR endobronchial brachytherapy is an effective method to re

89 had minimal symptomatic improvement with HDR endobronchial brachytherapy.

90 mptoms due to relapse or persistent tumor of endobronchial bronchogenic origin.

91 We collected endobronchial brush (EB) and bronchoalveolar lavage (BAL

92 ere obtained by BAL, and BE were obtained by endobronchial brush biopsy from 15 grain handlers 6 h af

93 ed tomography-guided transthoracic biopsy or endobronchial brushing for undiagnosed nodules.

94 s (5 signatures), sputum (3 signatures), and endobronchial brushings (6 signatures).

95 utum (n = 83), nasal brushings (n = 41), and endobronchial brushings (n = 65) and biopsies (n = 47) (

96 Endobronchial brushings and biopsies were obtained and e

97 7 [2-14] years) underwent bronchoscopy with endobronchial brushings and biopsies.

98 DNA was extracted from endobronchial brushings and bronchoalveolar lavage fluid

99 in cultured bronchial epithelial cells from endobronchial brushings of both subject groups.

100 bronchoscopy, bronchoalveolar lavage (BAL), endobronchial brushings, and biopsy.

101 enrichment for T-lymphocyte infiltration in endobronchial brushings.

102 10(9) colony-forming units (CFU) GBS via an endobronchial catheter (n = 7).

103 Bronchial rheoplasty uses an endobronchial catheter to apply nonthermal pulsed electr

104 RNA sequencing of endobronchial cell brushings confirmed a Muc5AC increase

105 analyses (ie, surgery, endobronchial valve, endobronchial coil, or sclerosing agents), the mean diff

106 Our findings suggest that treatment with endobronchial coils can improve quality of life for pati

107 rinflation treated for 12 months, the use of endobronchial coils compared with usual care resulted in

108 inary clinical trials have demonstrated that endobronchial coils compress emphysematous lung tissue a

109 Endobronchial coils might have a role in the treatment o

110 While accepting that chronic endobronchial colonization with atypical mycobacteria ma

111 porcine lung and to compare percutaneous and endobronchial delivery methods.

112 g the prostacyclin analogue iloprost reduces endobronchial dysplasia, a premalignant lung lesion.

113 Endobronchial endotoxin was followed by progressive alve

114 immediately extravascular by using primarily endobronchial forceps for caval fragments and snares for

115 The endobronchial forceps technique can be safely used to re

116 The endobronchial forceps technique was used to successfully

117 then removed through the sheath by using the endobronchial forceps.

118 Ablation zones created after endobronchial gel injection were more uniform in size di

119 on explanted oxygenator fibers.Conclusions: Endobronchial hMSC therapy in an ovine model of ARDS and

120 Subsequently, they received either endobronchial induced pluripotent stem cell-derived huma

121 al antibodies, variable bacterial clearance, endobronchial infection and microbial adaptation with PA

122 f the inflammatory response to P. aeruginosa endobronchial infection and that further investigation i

123 Pseudomonas aeruginosa endobronchial infection causes significant morbidity and

124 Chronic endobronchial infection frequently caused by gram-negati

125 and systemic morbidity in mice with chronic endobronchial infection with P. aeruginosa embedded in a

126 ized by abnormal airways secretions, chronic endobronchial infection, and progressive airway obstruct

127 urine model of mucoid Pseudomonas aeruginosa endobronchial infection.

128 sociated with chronic Pseudomonas aeruginosa endobronchial infection.

129 using an animal model of chronic Pseudomonas endobronchial infection.

130 eudomonas aeruginosa strains causing chronic endobronchial infections in cystic fibrosis is their con

131 known as mucoidy, is associated with chronic endobronchial infections in cystic fibrosis.

132 n zone volume than those performed following endobronchial injection (percutaneous vs endobronchial,

133 l accelerant into the lung (n = 16) or after endobronchial injection by using a flexible bronchoscope

134 a larger ablation zone volume compared with endobronchial injection, whereas a more homogeneous and

135 induced ventilator-associated pneumonia via endobronchial instillation of either Escherichia coli gr

136 0.734; 95% CI, 0.630-0.833), especially for endobronchial intubation (AUC: NTUH-20, 0.991; 95% CI, 0

137 roup was probably associated with accidental endobronchial intubation following tube movement.

138 n with excellent performance, especially for endobronchial intubation, and with favorable potential f

139 c intubation, aspiration, dental injury, and endobronchial intubation.

140 opious secretions and in cases of accidental endobronchial intubation.

141 on Wegener's-related subglottic stenosis and endobronchial involvement, it has also become apparent t

142 Analysis of cytokine protein levels in endobronchial lavage (EBL) fluid demonstrated that only

143 The missed tumors manifested as endobronchial lesion (n = 10), solitary parenchymal nodu

144 = 5), pleural effusion (n = 4), and solitary endobronchial lesion (n = 2).

145 ruction promptly for patients with recurrent endobronchial lesions and may be considered as a boost f

146 owever, LC risk in patients with preinvasive endobronchial lesions is unclear.

147 hese results show that proteomic analysis of endobronchial lesions may facilitate the diagnosis of lu

148 Endobronchial location and lower lobe predominance were

149 we evaluated whether eosinophils within the endobronchial lumen can function in vivo as antigen-pres

150 Either bronchoscopy with transbronchial and endobronchial lung biopsies or endosonography (esophagea

151 al model of cisplatin pharmacodynamics in an endobronchial lung tumor following ultrasound-guided tra

152 s were predominately found at peripheral and endobronchial lung, respectively.

153 Endobronchial lymphocytic bronchitis was more prevalent

154 The association of endobronchial lymphocytic inflammation and BOS may have

155 for the treatment of lung, mediastinal, and endobronchial metastases, with no severe adverse events.

156 horax and chest tube insertion compared with endobronchial methods.

157 Endobronchial mucosal biopsies were stained with Periodi

158 ning, Lung-RADS, Nodule Risk, Airway Nodule, Endobronchial Nodule (C) RSNA, 2024.

159 ween 2015 and 2021 with a reported airway or endobronchial nodule.

160 The LLL was subsequently collapsed by endobronchial occlusion following 10 min of 100% O2.

161 Endobronchial optical coherence tomography (EB-OCT) is a

162 Endobronchial optical coherence tomography (EB-OCT) is a

163 ents with unresectable and unablatable lung, endobronchial, or mediastinal metastases, who failed sys

164 e safely or effectively delivered, including endobronchial procedures using flexible or rigid broncho

165 ad severe alveolar inflammation and probable endobronchial sarcoidosis.

166 rs that control this homing pattern, we used endobronchial segmental allergen challenge in human atop

167 n CF, which typically remain confined to the endobronchial spaces, B. cenocepacia can traverse airway

168 10(9) plaque-forming units over 9 months by endobronchial spray to 7 pairs of individuals with CF.

169 Twenty-three patients underwent endobronchial stenting (50.0%) and each patient needed a

170 airway pathologies that require placement of endobronchial stents.

171 mechanical ventilator, pleural catheter, and endobronchial strategies for the management of bronchopl

172 m the lower airways of children with chronic endobronchial suppuration.

173 Endobronchial tamponade should only be used as a tempora

174 Preparation for other interventions (endobronchial tamponade, BAE, or surgery in eligible can

175 these polymorphisms were also compared with endobronchial tissue inflammatory cells and local IgE.

176 who underwent lung transplantation underwent endobronchial tissue oximetry of native and donor bronch

177 Compared with native endobronchial tissues, donor tissue oxygen saturations (

178 Intubation with a 37-Fr double-lumen endobronchial tube and ventilation with two oscillatory

179 e a primary xenograft model of SCLC in which endobronchial tumor specimens obtained from chemo-naive

180 Endobronchial ulstrasound-guided core biopsies of the lu

181 ng biopsies or endosonography (esophageal or endobronchial ultrasonography) with aspiration of intrat

182 Endobronchial ultrasonography-guided transbronchial need

183 e lung cancer staging has evolved to include endobronchial ultrasonography-guided transbronchial need

184 ures and lymph nodes, is clearly imaged with endobronchial ultrasonography; (3) a greater short-axis

185 Endobronchial ultrasound (EBUS) and spiral chest compute

186 nsthoracic biopsy (EMN-TTNA) and staging via endobronchial ultrasound (EBUS).

187 Cytology reports for endobronchial ultrasound (EBUS)/endoscopic ultrasound (E

188 he diagnostic yield was 63.7% when no radial endobronchial ultrasound (r-EBUS) and no EMN were used,

189 T-CT), followed by mediastinal staging using endobronchial ultrasound and endoscopic ultrasound imagi

190 was to determine the diagnostic accuracy of endobronchial ultrasound and spiral chest CT scan in the

191 Transbronchial needle aspiration guided by endobronchial ultrasound should be considered as the ini

192 The Endobronchial Ultrasound Skills and Tasks Assessment Too

193 underwent preoperative staging with PET-CT, endobronchial ultrasound, and endoscopic ultrasound, fol

194 e imaging, optical coherence tomography, and endobronchial ultrasound, are now being used to examine

195 g of mediastinal lymph nodes, but, recently, endobronchial ultrasound-guided (EBUS) fine-needle aspir

196 mine whether the next step should be biopsy (endobronchial ultrasound-guided biopsy or mediastinoscop

197 to T3, N0 to N3, and M0 NSCLC who underwent endobronchial ultrasound-guided staging from a single ce

198 The role of endobronchial ultrasound-guided transbronchial needle as

199 Endobronchial ultrasound-guided transbronchial needle as

200 Endobronchial ultrasound-guided transbronchial needle as

201 Endobronchial ultrasound-guided transbronchial needle as

202 ses in 3 patients (1 confirmed, 1 systematic endobronchial ultrasound-guided transbronchial needle as

203 Consensus TNM staging (derived from CT, endobronchial ultrasound-guided transbronchial needle as

204 ing classifiers to predict LN-involvement by endobronchial ultrasound-guided transbronchial needle as

205 N2 or N3 (prN2/3) malignant nodal disease on endobronchial ultrasound-guided transbronchial needle as

206 We aimed to assess endobronchial ultrasound-guided transbronchial needle as

207 centres and randomly assigned them to either endobronchial ultrasound-guided transbronchial needle as

208 on on yield, complications, and tolerance of endobronchial ultrasound-guided transbronchial needle as

209 Real-time endobronchial ultrasound-guided transbronchial needle as

210 Intratumoral delivery of cisplatin by endobronchial ultrasound-guided transbronchial needle in

211 iltrating lymph nodes in patients undergoing endobronchial ultrasound.

212 r randomized controlled trials of the Zephyr endobronchial valve (EBV) treatment have demonstrated be

213 ilot study of unilateral volume reduction by endobronchial valve insertion.

214 subjects with severe emphysema who underwent endobronchial valve LVR were analyzed retrospectively us

215 Endobronchial valve placement can improve lung volumes a

216 Endobronchial valve placement improves pulmonary functio

217 ive pulmonary disease who recently underwent endobronchial valve placement.

218 Fissure integrity assessment is important to endobronchial valve treatment screening.

219 300 patients with severe emphysema underwent endobronchial valve treatment.

220 terventions in pooled analyses (ie, surgery, endobronchial valve, endobronchial coil, or sclerosing a

221 We compared the safety and efficacy of endobronchial-valve therapy in patients with heterogeneo

222 e of collateral ventilation to bronchoscopic endobronchial-valve treatment (EBV group) or to continue

223 Endobronchial-valve treatment for advanced heterogeneous

224 Endobronchial-valve treatment significantly improved pul

225 ause lobar segments were inaccessible to the endobronchial valves (3 patients).

226 ients, 220 were randomly assigned to receive endobronchial valves (EBV group) and 101 to receive stan

227 Endobronchial valves are designed to exclude the most af

228 For example, the placement of endobronchial valves can substitute for lung reduction s

229 Previous trials with endobronchial valves have yielded modest group benefits

230 Unilateral lobar occlusion with endobronchial valves in patients with heterogeneous emph

231 Insertion of endobronchial valves in selected patients could have ben

232 ung-volume reduction with the use of one-way endobronchial valves is a potential treatment for patien

233 nchoscopic lung volume reduction (BLVR) with endobronchial valves is a treatment option to reduce pul

234 reduction of hyperinflation using BLVR with endobronchial valves significantly improved cardiac prel

235 Endobronchial valves that allow air to escape from a pul

236 The most widely used BLVR devices are: endobronchial valves, foam sealant, metallic coils, airw

237 f predicted) who were eligible for BLVR with endobronchial valves.

238 s were cultured from patient sputum (n = 3), endobronchial washings (n = 3), pleural fluid (n = 1), a